Revvity (RVTY) Non-Current Assets (2010 - 2026)
Revvity's (RVTY) quarterly Non-Current Assets came in at $9.7 billion in Q3 2026, down 3.74% on a YoY basis from $10.1 billion in Q3 2025, and down 1.22% quarter-over-quarter from $9.9 billion in Q2 2026.
Analysis
Revvity (RVTY) Non-Current Assets (2010 - 2026) Analysis & Trends
Revvity (RVTY) has reported Non-Current Assets for 17 consecutive years, with $9.7 billion the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Non-Current Assets fell 3.74% year-over-year to $9.7 billion; the trailing twelve-month figure through Jul 2026 stood at $39.5 billion (down 2.45% YoY), and the FY2025 full-year result was $9.9 billion, down 1.14% from the prior year.
- Non-Current Assets declined to $9.7 billion in Q3 2026 per RVTY's latest filing, from $9.9 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $12.6 billion in Q1 2022 and bottomed at $9.7 billion in Q3 2026.
- Historically, Non-Current Assets has averaged $10.6 billion across 5 years, with a median of $10.4 billion in 2024.
- The widest YoY moves for Non-Current Assets: up 119.52% in 2022, down 15.35% in 2022.
- Over 5 years, Non-Current Assets stood at $10.7 billion in 2022, then declined by 1.34% to $10.6 billion in 2023, then declined by 4.93% to $10.0 billion in 2024, then fell by 1.14% to $9.9 billion in 2025, then dropped by 1.82% to $9.7 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $9.7 billion, $9.9 billion, and $9.9 billion for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 89.81 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 78.99 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 9.27 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 3.82 Bn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 9.75 Bn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 1.84 Bn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 7.23 Bn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 1.75 Bn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 355.40 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 3.83 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 9.75 Bn |
| Apr 5, 2026 | 9.87 Bn |
| Dec 28, 2025 | 9.93 Bn |
| Sep 28, 2025 | 10.00 Bn |
| Jun 29, 2025 | 10.13 Bn |
| Mar 30, 2025 | 10.04 Bn |
| Dec 29, 2024 | 10.04 Bn |
| Sep 29, 2024 | 10.32 Bn |
| Jun 30, 2024 | 10.27 Bn |
| Mar 31, 2024 | 10.37 Bn |
| Dec 31, 2023 | 10.56 Bn |
| Oct 1, 2023 | 10.51 Bn |
| Jul 2, 2023 | 10.70 Bn |
| Apr 2, 2023 | 10.84 Bn |
| Jan 1, 2023 | 10.84 Bn |
| Oct 2, 2022 | 10.71 Bn |
| Jul 3, 2022 | 12.08 Bn |
| Apr 3, 2022 | 12.39 Bn |
| Jan 2, 2022 | 12.56 Bn |
| Oct 3, 2021 | 12.65 Bn |